WASHINGTON — The federal government’s years-long debate over marijuana’s legal status has entered another critical stage, with the Drug Enforcement Administration releasing more than 2,500 pages of testimony from its rescheduling hearing as the judge overseeing the case prepares his recommendation.
For Michigan’s cannabis industry, however, the bigger question isn’t what’s contained in the massive transcript.
It’s what happens next — and whether federal marijuana reform will provide meaningful relief to a Michigan cannabis market that is now almost entirely recreational.
DEA Chief Administrative Law Judge Derek Julius has released the corrected transcript covering 11 days of hearings that concluded July 15. The official record runs 2,533 pages and documents arguments over whether marijuana should remain among the nation’s most tightly controlled drugs or receive less restrictive treatment under federal law.
Julius must now evaluate that record and issue a recommendation to DEA Administrator Terry Cole.
The recommendation will not itself determine federal marijuana policy. But it represents another major step in a process that could eventually reshape taxation, research and investment throughout America’s cannabis industry.
5 Things Schedule III Would — And Would Not — Do For Michigan Cannabis
1. Could provide major federal tax relief.
Section 280E applies to Schedule I and II controlled substances. Moving marijuana to Schedule III could eliminate that restriction for marijuana businesses, allowing ordinary business deductions that most industries already receive.2. Would not legalize recreational marijuana nationwide.
Rescheduling and legalization are different. Michigan’s recreational industry could remain legal under state law but prohibited under federal law.3. Would not automatically allow Michigan marijuana exports.
Michigan growers couldn’t simply begin shipping surplus recreational cannabis to Ohio, Illinois or other states. Interstate commerce would require additional changes in federal law or policy.4. Could reduce barriers to marijuana research.
Schedule III could make federally authorized research easier and encourage additional study of marijuana’s medical uses, effectiveness and risks.5. Michigan’s market is overwhelmingly recreational.
July adult-use sales reached $270.54 million, compared with only $311,726 in medical marijuana sales. Adult-use sales were approximately 868 times larger, meaning the practical value of federal reform to Michigan depends heavily on how it affects the recreational industry.DEA Defends Schedule III
One of the most significant developments during the proceeding was the position taken by the federal government itself.
In its post-hearing arguments, the government defended the scientific and medical analysis supporting Schedule III and challenged testimony presented by opponents of rescheduling.
At the center of the government’s case is a Department of Health and Human Services finding that marijuana has a currently accepted medical use — a conclusion fundamentally at odds with marijuana’s longstanding Schedule I classification.
Schedule I is reserved for controlled substances considered to have no currently accepted medical use and a high potential for abuse.
Opponents of rescheduling challenged the government’s scientific analysis and raised concerns involving marijuana abuse, public health, impaired driving and youth exposure.
Julius must now weigh those competing arguments before issuing his recommendation.
Michigan’s Market Is Almost Entirely Recreational
Michigan has more at stake in the federal debate than most states.
The state has developed one of the nation’s largest legal recreational marijuana markets, generating billions of dollars in annual sales while simultaneously experiencing severe price compression, oversupply and industry consolidation.
But perhaps the most important number for understanding how federal rescheduling could affect Michigan is $311,725.63.
That’s how much medical marijuana Michigan sold during the entire month of July, according to the Michigan Cannabis Regulatory Agency.
By comparison, Michigan recreational marijuana sales totaled $270.54 million during July.
Adult-use sales were approximately 868 times larger than medical sales.
Medical marijuana accounted for only about 0.12 percent of the combined $270.85 million regulated cannabis market in July.
Those numbers illustrate just how dramatically Michigan’s cannabis industry has changed since recreational sales began.
Michigan essentially has become an adult-use marijuana market with a tiny remaining medical component.
And that makes the details of federal rescheduling particularly important.
Schedule III Isn’t Recreational Legalization
Moving marijuana to Schedule III would be a historic change in federal drug policy.
But it would not be the same thing as Congress legalizing recreational marijuana nationwide.
Michigan could continue operating its state-regulated recreational market while adult-use marijuana remains prohibited under federal law.
That’s a crucial distinction when more than 99 percent of Michigan’s regulated marijuana sales now come from the recreational side of the business.
Federal recognition of marijuana’s medical uses therefore doesn’t automatically resolve the legal conflicts surrounding Michigan’s enormous adult-use industry.
Nor would Schedule III automatically solve another major Michigan problem: oversupply.
Michigan growers could not simply begin shipping excess recreational marijuana to Ohio, Illinois or other states because interstate marijuana commerce would remain prohibited without additional changes in federal law or policy.
For Michigan operators, that means rescheduling could be enormously important without fixing some of the industry’s biggest structural problems.
The Federal Tax Question Could Be Huge
One potential benefit, however, could directly affect the bottom lines of cannabis companies.
Section 280E of the federal tax code prevents businesses trafficking in Schedule I or Schedule II controlled substances from deducting ordinary business expenses when calculating federal taxable income.
That has produced an extraordinary situation for state-licensed cannabis companies.
Businesses operating legally under Michigan law can face federal tax bills calculated under rules that prevent them from deducting many of the expenses routinely deducted by other businesses.
Moving marijuana to Schedule III could remove marijuana businesses from the reach of 280E, potentially providing substantial federal tax relief.
For struggling Michigan operators, that could be worth millions of dollars across the industry.
The timing could be particularly significant.
Michigan cannabis businesses already face intense competition, falling retail prices and a 24 percent wholesale marijuana tax that took effect Jan. 1.
That Michigan tax is being challenged in court, with the Michigan Supreme Court potentially determining its legality.
Federal tax relief therefore could arrive at an especially important moment for Michigan cannabis businesses.
5 Things Schedule III Would — And Would Not — Do For Michigan Cannabis
1. Could provide major federal tax relief.
Section 280E applies to Schedule I and II controlled substances. Moving marijuana to Schedule III could eliminate that restriction for marijuana businesses, allowing ordinary business deductions that most industries already receive.
2. Would not legalize recreational marijuana nationwide.
Rescheduling and legalization are different. Michigan’s recreational industry could remain legal under state law but prohibited under federal law.
3. Would not automatically allow Michigan marijuana exports.
Michigan growers couldn’t simply begin shipping surplus recreational cannabis to Ohio, Illinois or other states. Interstate commerce would require additional changes in federal law or policy.
4. Could reduce barriers to marijuana research.
Schedule III could make federally authorized research easier and encourage additional study of marijuana’s medical uses, effectiveness and risks.
5. Michigan’s market is overwhelmingly recreational.
July adult-use sales reached $270.54 million, compared with only $311,726 in medical marijuana sales. Adult-use sales were approximately 868 times larger, meaning the practical value of federal reform to Michigan depends heavily on how it affects the recreational industry.
What Happens Next?
Julius’ recommendation will go to DEA Administrator Terry Cole.
Because the administrative law judge’s recommendation is not binding, the DEA administrator ultimately retains authority over the agency’s final decision.
And whatever DEA decides could face additional legal challenges.
That means marijuana’s federal status isn’t necessarily going to change overnight.
But after years of administrative reviews, proposed rules, delays and legal maneuvering, the federal government is getting closer to answering one of the most consequential questions facing the cannabis industry.
For Michigan, there are actually two questions:
Will marijuana finally move permanently away from Schedule I?
And perhaps more importantly for a state where virtually the entire commercial cannabis market is recreational:
How much will Michigan’s $270-million-a-month adult-use marijuana industry actually benefit?
[{“@context”:”https://schema.org”,”@type”:”NewsArticle”,”headline”:”DEA Marijuana Decision Moves Closer — What Schedule III Could Mean For Michigan”,”description”:”The DEA has released the full marijuana rescheduling hearing transcript as a federal judge prepares his recommendation, raising major questions for Michigan’s overwhelmingly recreational cannabis market.”,”author”:{“@type”:”Person”,”name”:”Mike Brennan”},”publisher”:{“@type”:”Organization”,”name”:”MITechNews”},”datePublished”:”2026-08-26″,”dateModified”:”2026-08-26″,”mainEntityOfPage”:{“@type”:”WebPage”,”@id”:”https://mitechnews.com/”}}]
